Stability of colistin and colistin methanesulfonate in aqueous media and plasma as determined by high-performance liquid chromatography

被引:179
作者
Li, J
Milne, RW [1 ]
Nation, RL
Turnidge, JD
Coulthard, K
机构
[1] Univ S Australia, Pharmaceut Res Ctr, Adelaide, SA 5000, Australia
[2] Womens & Childrens Hosp, Dept Microbiol & Infect Dis, Adelaide, SA 5006, Australia
[3] Womens & Childrens Hosp, Dept Pharm, Adelaide, SA 5006, Australia
关键词
D O I
10.1128/AAC.47.4.1364-1370.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The stabilities of colistin and colistin methanesulfonate (CMS) in different aqueous media were studied by specific high-performance liquid chromatography (HPLC) methods. Colistin was stable in water at 4 and 37degreesC for up to 60 days and 120 h, respectively. However, degradation was observed when colistin was stored in isotonic phosphate buffer (0.067 M, pH 7.4) and human plasma at 37degreesC. The stability of CMS from three different sources in water was explored by strong-anion-exchange (SAX) HPLC for CMS and by measuring the concentrations of colistin formed from the hydrolysis of CMS. The peaks of CMS in SAX HPLC disappeared almost completely after 12 h at 37degreesC, but appeared to remain intact for up to 2 days at 4degreesC. Over the same period, there was no formation of colistin at 4degreesC. In water, phosphate buffer, and plasma, there was rapid formation of colistin within 24 to 48 h at 37degreesC from the three sources of CMS. The hydrolysis products were assumed to be a complex mixture of many different sulfomethyl derivatives, including colistin. The stability of a fourth source of CMS in Mueller-Hinton broth examined during 30 min at 37degreesC revealed no formation of colistin. Along with previous microbiological studies, this suggested that different sulfomethyl CMSs possess intrinsic antibacterial activity. These results will be helpful for understanding the pharmacokinetics and pharmacodynamics of colistin and CMS in humans and animals.
引用
收藏
页码:1364 / 1370
页数:7
相关论文
共 13 条
  • [1] PHARMACOLOGIC AND TOXICOLOGIC STUDIES WITH POLYMYXINS .2. COMPARATIVE PHARMACOLOGIC STUDIES OF SULFATE AND METHANESULFONATE SALTS OF POLYMYXIN-B AND COLISTIN IN DOGS
    ALKHAYYAT, AA
    ARONSON, AL
    [J]. CHEMOTHERAPY, 1973, 19 (02) : 82 - 97
  • [2] SODIUM SULPHOMETHYL DERIVATIVES OF POLYMYXINS
    BARNETT, M
    BUSHBY, SRM
    WILKINSON, S
    [J]. BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1964, 23 (03): : 552 - +
  • [3] SODIUM SULPHOMETHYL DERIVATIVES OF POLYMYXINS
    BEVERIDGE, EG
    MARTIN, AJ
    [J]. BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1967, 29 (02): : 125 - +
  • [4] Hyphenated liquid chromatographic method for the determination of colistin residues in bovine tissues
    Decolin, D
    Leroy, P
    Nicolas, A
    Archimbault, P
    [J]. JOURNAL OF CHROMATOGRAPHIC SCIENCE, 1997, 35 (12) : 557 - 564
  • [5] Koyama Y., 1950, J.Antibiot, V3, P457
  • [6] RESIDUE DETERMINATION OF 2 CO-ADMINISTERED ANTIBACTERIAL AGENTS CEPHALEXIN AND COLISTIN IN CALF TISSUES USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND MICROBIOLOGICAL METHODS
    LEROY, P
    DECOLIN, D
    NICOLAS, S
    ARCHIMBAULT, P
    NICOLAS, A
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1989, 7 (12) : 1837 - 1846
  • [7] Simple method for assaying colistin methanesulfonate in plasma and urine using high-performance liquid chromatography
    Li, J
    Milne, RW
    Nation, RL
    Turnidge, JD
    Coulthard, K
    Valentine, J
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (10) : 3304 - 3307
  • [8] A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversed-phase high-performance liquid chromatography
    Li, J
    Milne, RW
    Nation, RL
    Turnidge, JD
    Coulthard, K
    Johnson, DW
    [J]. JOURNAL OF CHROMATOGRAPHY B, 2001, 761 (02): : 167 - 175
  • [9] In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis
    Li, J
    Turnidge, J
    Milne, R
    Nation, RL
    Coulthard, K
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (03) : 781 - 785
  • [10] A ten year review of Colomycin
    Littlewood, JM
    Koch, C
    Lambert, PA
    Hoiby, N
    Elborn, JS
    Conway, SP
    Dinwiddie, R
    Duncan-Skingle, F
    [J]. RESPIRATORY MEDICINE, 2000, 94 (07) : 632 - 640